Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 109-120 of 1339
» View ktuu.com items only
    Apr 17, 2013 |Story| Los Angeles Times
  1. Scientists sequence DNA of a 'living fossil': the coelacanth

    They're big, they're furtive, they're weird-looking. You almost certainly wouldn't want to dine on one, since they're endangered and are said to cause digestive distress in people who eat them.
    They're big, they're furtive, they're weird-looking. You almost certainly wouldn't want to dine on one, since they're endangered and are said to cause digestive distress in people who eat them. But the African coelacanth is extremely useful in at...

    Tags: Chemical Industry, Fossils, Stranger Than Fiction, Science and Technology, Africa

  2. Apr 15, 2013 |Story| Los Angeles Times
  3. Can a company patent your DNA? Supreme Court hears BRCA gene case

    Can a private company own rights to your DNA?
    Can a private company own rights to your DNA? The nine justices of the Supreme Court will consider that question Monday as lawyers for Myriad Genetics make their best case that the company should be able to keep its patent on two genes known to...

    Tags: Medical Research, Business Enterprises, Genetics, Science, Myriad Genetics Incorporated

  4. Apr 15, 2013 |Story| Los Angeles Times
  5. Supreme Court critical of patents on human genes

    WASHINGTON — The Supreme Court justices said Monday they were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them.
    WASHINGTON — The Supreme Court justices said Monday they were highly skeptical of the idea that a company or a scientist can hold a patent on human genes and prevent others from testing or using them. “What about the first person who found a...

    Tags: Medical Research, Invention and Innovation, Lawyers, Civil Rights, Stephen Breyer

  6. Apr 15, 2013 |Story| Los Angeles Times
  7. Supreme Court to consider validity of patents on genes

    WASHINGTON -- The Supreme Court will hear an appeal Monday from breast cancer patients and medical researchers who say the U.S. Patent and Trademark Office made a mistake when it granted a Utah company an exclusive right to profit from testing genes that signal a high risk of cancer.
    WASHINGTON -- The Supreme Court will hear an appeal Monday from breast cancer patients and medical researchers who say the U.S. Patent and Trademark Office made a mistake when it granted a Utah company an exclusive right to profit from testing genes...

    Tags: Invention and Innovation, Lawyers, Stephen Breyer, Myriad Genetics Incorporated, Breast Cancer

  8. Apr 15, 2013 |Story| Los Angeles Times
  9. Supreme Court considers gene patents; scientists react

    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims.
    As the U.S. Supreme Court heard oral arguments in the case against Myriad Genetics, scientists who are skeptical of the idea of patenting genes said they were hopeful that the justices would overturn the Utah company's claims. "I was on pins and needles...

    Tags: Science, Myriad Genetics Incorporated, Patents, Copyrights and Trademarks, Chemical Industry, Science and Technology

  10. Apr 15, 2013 |Story| Los Angeles Times
  11. Why genetic patents are good for patients [Blowback]

    <span class="toolSet" style="width: 335px;"><span class="byline">In their April 12 Op-Ed article "<a href="http://www.latimes.com/news/opinion/commentary/la-oe-darnovsky-breast-genes-patents-20130412,0,2847752.story">Who should own DNA? All of us</a>," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they have served little purpose in the development of tests that have helped more than 1 million women to understand their risks of breast cancer and ovarian cancer.</span></span>
    In their April 12 Op-Ed article "Who should own DNA? All of us," Marcy Darnovsky and Karuna Jaggar write about Myriad's patents on BRCA1 and BRCA2, the so-called breast cancer genes (which were under review Monday at the U.S. Supreme Court), as if they...

    Tags: Medical Research, Chemical Industry, Science and Technology, Medical Procedures and Tests, U.S. Supreme Court

  12. Apr 15, 2013 |Story| Los Angeles Times
  13. The Supreme Court looks at gene patents, worries about biotech

    When the Supreme Court took up the question Monday of <a href="http://www.latimes.com/news/politics/la-pn-supreme-court-patents-human-genes-20130415,0,2991661.story">whether genes could be patented</a>, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes cuts both ways, leading to a potential split among the justices.
    When the Supreme Court took up the question Monday of whether genes could be patented, the justices were clearly concerned about preserving innovation in medicine and biotechnology. But the issue presented by Myriad Genetics' patents on the BRCA genes...

    Tags: Medical Research, Invention and Innovation, Lawyers, Science, Myriad Genetics Incorporated

  14. Apr 12, 2013 |Story| Los Angeles Times
  15. Who should own DNA? All of us

    Most court cases involving patent law are corporate battles, with one company suing another for infringing on its intellectual property rights and, therefore, profits. Big companies fighting over big money can seem painfully irrelevant, especially when so many of us are simply struggling to get by.
    Most court cases involving patent law are corporate battles, with one company suing another for infringing on its intellectual property rights and, therefore, profits. Big companies fighting over big money can seem painfully irrelevant, especially when so...

    Tags: Invention and Innovation, Civil Rights, Polio, Women's Health, Myriad Genetics Incorporated

  16. Apr 14, 2013 |Story| Baltimore Sun
  17. Murder trial shifts to woman's body found in Elkridge backyard

    When Howard County authorities said they found the badly decomposed remains of Christine Jarrett beneath a shed in her own backyard, they moved swiftly to charge her husband &mdash; long a suspect &mdash; with the murder.
    When Howard County authorities said they found the badly decomposed remains of Christine Jarrett beneath a shed in her own backyard, they moved swiftly to charge her husband — long a suspect — with the murder. That discovery — two...

    Tags: Court Preliminary, Lawyers, Murder, Maryland State Police, Identification Technology

  18. Mar 22, 2013 |Story| Aberdeen News
  19. SDSU works toward developing drought-tolerant wheat

    BROOKINGS - South Dakota State University scientists must develop varieties of wheat that can tolerate drought, according to molecular biologist Jai Rohila, assistant professor of biology and microbiology. That is the key to making agriculture sustainable...

    Tags: Colleges and Universities, U.S. Department of Agriculture, Education, Physical Fitness and Exercise, Egypt

  20. Apr 8, 2013 |Story| Los Angeles Times
  21. Handyman arrested in slaying of San Bernardino woman, 76

    San Bernardino police arrested a neighborhood handyman in connection with the violent, home-invasion slaying of a 76-year-old woman in November, authorities said Monday, adding that the suspect could also possibly be linked to two other elderly women who were killed while alone in their homes.
    San Bernardino police arrested a neighborhood handyman in connection with the violent, home-invasion slaying of a 76-year-old woman in November, authorities said Monday, adding that the suspect could also possibly be linked to two other elderly women...

    Tags: Chemical Industry, Sex Crimes, Murder, Lifestyle and Leisure, Sexual Assault

  22. Apr 6, 2013 |Column| South Florida Sun-Sentinel
  23. Can Anthony Caravella ever get true justice?

    Anthony Caravella spent nearly 26 years in prison for a 1983 murder he didn't commit. He can't get that time back. But a federal jury ruled Caravella should get $7 million from two former Miramar cops who railroaded him.
    Anthony Caravella spent nearly 26 years in prison for a 1983 murder he didn't commit. He can't get that time back. But a federal jury ruled Caravella should get $7 million from two former Miramar cops who railroaded him. If there was true justice in the...

    Tags: Justice System, Chemical Industry, Pension and Welfare, Broward County Sheriff's Office, Politics

< Previous1 2 3 4 5 6 7 8 9  10  11-112Next >
Original site for Biotechnology Industry topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Biotechnology Industry Photos
Baltimore, MD--May 15, 2013--This is Eddy C. Agbo, Chai...
(May 15, 2013)
Eddy Agbo, chairman and CEO of Fyodor Biotechnologies Corp.
Thousand Oaks-based biotechnology company Amgen Inc. ha...
(May 14, 2013)
 6: Amgen Inc.
St. Joseph University biology professor Dr. Irene Gutti...
(May 5, 2013)
Saint Joseph STEM Expo